Sat. October 07, 2017

You Are Invited to Attend the Inaugural CME/CNE Accredited Scientific Conference!

You Are Invited to Attend the Inaugural CME/CNE Accredited Scientific Conference!
                                                                  2017 Breast Immune-Oncology Conference
                                                        
Date: Saturday, October 7th, 2017

Time: 8:00am-3:00pm

Location: Moffitt Cancer Center
                 Stabile Research Building (SRB)*
                 12902 USF Magnolia Drive
                 Tampa, FL 33612

mahajan srb





Information about the 2017 Breast Immune-Oncology Conference

Under the direction of Program Chair, Brian Czerniecki, MD, PhD, and in partnership with Moffitt Cancer Center, The Florida Society of Clinical Oncology (FLASCO), and the accreditor, Rush University Medical Center of Chicago, the 2017 Breast Immune-Oncology Conference will be a first in class scientific event dedicated to the advancement of immune-oncology in breast cancer.

The goal of this conference is to examine the role of the immune system in breast cancer, along with the rationale for immunotherapy as a treatment for breast cancer, results from ongoing clinical trials of immunotherapies in breast cancer and learn of current opportunities for trials actively accruing in breast immune-oncology. Attendees will learn about the appropriate clinical trials of immunotherapies for patients with breast cancer, as well as gain insights into the use of standard therapies such as chemotherapy and radiation and how these modalities impact both favorably and unfavorably on the tumor immune response.

Target Audience:
This activity is designed to meet the educational needs of healthcare professionals involved in the treatment of patients with breast cancer.

Registration Fee: 

Physicians:
Advance: $179.00  On-site: $225.00

Fellows:
Advance: $99.00  On-site: $125.00

Nurses, NP, PAs, Pharm, Other:
Advance: $99.00  On-site: $125.00

Moffitt Clinicians: 
Fee is waived

Industry:
Advance: $279.00  On-site: $325.00

Providers: 
This activity is co-provided by Moffitt Cancer Center, the Florida Society of Clinical Oncology (FLASCO), Rush University, Plexus Communications, and Pennies in Action.
Moffitt       FL LOGO Use This     Rush Logo MasterBrndTransparent     PleXus Logo 2.0       pennies 

Educational Objectives:

1. Review fundamentals of immunology to develop a baseline of scientific understanding that can be applied to clinical translation

2. Describe cancer immunotherapy principles in the context of current therapy decisions for the treatment of breast cancer

3. Discuss promising immunotherapy approaches for breast cancer, including vaccines and the role of checkpoint blockade

4. Determine how knowledge of response criteria and biomarkers in other tumor types may be used or applied to provide insight in assessing response to immunotherapy

5. Summarize data from recent and ongoing clinical trials of vaccines and immunotherapies as well as combination therapies currently being studied in breast cancer


8:00am- 9:35am  Session I: The Role of Immune Response in Diagnosis and Prognosis and Prevention Radiation as an Immune Therapy in Breast Cancer

Introduction to Immunology in the Breast
         Jose Conejo-Garcia, MD, PhD 

TIL in Predicting Outcomes in Response to Therapy
          Lajos Pusztai, MD, DPhil

Chemokine Signature
          Anders Berglund, PhD

Th1 CD4 anti-Oncodriver Response as a Predictor of Response and Survival
          Gary Koski, PhD 


9:50am-11:05am  Session II: Unraveling Where Immunotherapy Can be Utilized in Breast Cancer

Natural and Therapy Induced Immunosurveillance in Breast Cancer Keynote Address:
       
 Guido Kroemer, MD, PhD 

The Role of Checkpoint Inhibitors in Breast Cancer Therapy
        Rita Nanda, MD  

Vaccines and their Potential in Breast Cancer Therapy
        Beth Mittendorf, MD, PhD


11:20am-12:45pm  Session III: Novel Combinations of Immune Based Therapies to Improve Outcomes

Chemotherapy and Immunogenic Cell Death and Combinations with Immune Therapy
        Leisha Emens, MD, PhD

Rationale for Oncolytic Therapy in Triple Negative Breast Cancer
        Hatem Soliman, MD  

Th1 Cytokines in Breast Cancer as an Opportunity to Combine with Other Therapies
        Brian Czerniecki, MD, PhD  

12:45pm-1:45pm: Industry Supported Lunch Symposium: Expanded Indication for a First-in-Class Oral Therapy for the Treatment of a Broad Range of Women With HR+/HER2- Metastatic Breast Cancer

1:45pm-2:40pm  Session IV: Radiation as an Immune Therapy in Breast Cancer

Radiation as an Immunotherapy Adjuvant
     
 Sungjune Kim, MD, PhD

Genomic Immune Signatures to Predict Response to Radiation
       Daniel Grass, MD, PhD  

2:40pm-3:00pm  Closing Remarks/Discussion
Accreditation Information: 

In support of improving patient care, Rush University Medical Center is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

Physician

Rush University Medical Center designates this Live Activity for a maximum of six (6) AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Nurse

Rush University is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Rush University designates this live activity for six (6) Continuing Education credits. This activity will fulfill Category 2 contact hour requirements for pharmacology for ANCC certified advanced practice nurses.

Pharmacist

This program is approved for 6.0 hours (0.6 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
Accomodations:

A room block for conference attendees has been set up at the Tampa Marriott Waterside Hotel & Marina. The reduced rate for Friday, October 6 and Saturday, October 7 is $239/night.

To make your reservations, 
go to https://aws.passkey.com/go/Moffitt
or call Reservations Toll-Free: 888-789-3090.
Reservations must be made on or before September 6, 2017 to ensure discounted group rate.

A free shuttle service will be provided between the Marriott and the Moffitt Cancer Center for all conference participants.

tpamc main01 r


Click "REGISTER" to attend the program

Categories: Symposia